Core Viewpoint - Longshen Rongfa has obtained a medical device production license from the Gansu Provincial Drug Administration, allowing its blood dialysis concentrate (powder) product to be produced and sold [1] Group 1: Company Developments - The acquisition of the medical device production license signifies that the company's blood dialysis concentrate (powder) product is now qualified for production and market sales [1] - The blood dialysis concentrate (powder) is utilized in the treatment of acute and chronic renal failure through blood dialysis, and it has been widely applied in clinical settings [1]

Core Viewpoint - The company, Longshen Rongfa (300534), has obtained a Medical Device Manufacturing License from the Gansu Provincial Drug Administration, allowing its blood dialysis concentrate (dry powder) product to be produced and sold [1] Group 1 - The acquisition of the Medical Device Manufacturing License signifies that the company's blood dialysis concentrate (dry powder) product is now qualified for production and market sales [1] - The blood dialysis concentrate (dry powder) is classified as a medical device used in the treatment of acute and chronic renal failure through blood dialysis, and it has been widely applied in clinical settings [1]